Skip to main content
. 2023 May 25;15(11):2912. doi: 10.3390/cancers15112912

Figure 1.

Figure 1

Main immunomodulatory effects of chemotherapeutic drugs. The drugs included in the figure may boost antitumor immunity by targeting immunosuppressive immune cells (mostly Tregs and MDSCs), activating NK cells, causing ICD, and stimulating antigen (Ag) presentation through dendritic cells and T cell activity. The dose of the drug seems to play a crucial role in its capability to stimulate the immune system.